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of radiolabeled anti-rat type II collagen antibody were detected in
the synovial ﬂuid 10 minutes and 24 hours post-IA administration
relative to the non-speciﬁc antibody.
Conclusions: Rapid clearance of a non-speciﬁc antibody from
the synovial ﬂuid and joint tissues is observed after IA dosing
to a normal rat knee joint. The data highlights that if sustained
drug exposure is required for efﬁcacy, the retention time of the
therapeutic needs to be increased. Sustained retention of an anti-
collagen II antibody in the rat joint suggests that binding to a
resident protein may extend antibody retention time.
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IN VITRO VALIDATION OF A VARUS LOADING DEVICE IN
THE RABBIT KNEE
M.L. Roemhildt1, B.C. Fleming2, B.D. Beynnon1, D. Churchill3
1Univ. of Vermont, Burlington, VT; 2Brown Univ., Providence, RI;
3MicroStrain, Williston, VT
Purpose: Methods of producing relevant and quantiﬁable load
alterations in vivo with which to study load-induced cartilage de-
generation are limited. A novel loading device has been developed
to apply a varus moment to the knee creating a chronic overload
to the medial compartment of the knee while allowing normal joint
function. The objective of this study is to conﬁrm the change in
load in the medial compartment of the rabbit knee with application
of a known target load.
Methods: The increase in medial compartment compressive load
generated by the Varus Loading Device (VLD) was measured
directly in vitro and compared to the predicted values. The VLD
is mounted via transcutaneous bone plates attached to the lateral
aspect of the femur and tibia (Fig. 1). The VLD allows moments to
be applied only during the designated treatment period, at other
times the moment can be disengaged by detaching the distal
portion of the load link.
Figure 1. VLD applied to a hind limb: (A) lateral view, (B) anterior view. Ap-
plication of the VLD results in an increase in compressive load in the medial
compartment by an amount P. The change in load can be modulated in a
controlled manner by setting the spring torque as shown by Eqn. 1 where: P
= change in contact load, T = torque setting of the spring, D = intercompart-
mental moment arm, L1 = load link moment arm, and L2 = tibia moment arm.
Eqn 1: P = T/D × L2/L1.
The VLD was installed on ﬁve, NZW rabbit, hind limbs. The
medial joint capsule was opened and the medial tibial plateau
was resected to a level 6 mm below the joint line. A load cell,
6mm dia. x 6mm tall, (ALD Design, NY) was inserted in the
resection cavity and cemented in place, maintaining the original
level of the joint line. The medial femoral condyle contacted the
load sensor ensuring that the entire compressive load developed
in the medial compartment was measured by the load cell. The
femoral head was mounted in a ball joint and the distal tibia was
ﬁxed in a clamp, positioned such that the femur was horizontal,
and the ﬂexion angle was approximately 115° to orient the tibial
plateau horizontally. A 100 N weight was attached to the femur
just proximal to the knee joint. This generated a compressive tibio-
femoral load approximately equally divided between the medial
and lateral compartments to simulate the physiologic joint load
normally present in the knee due to muscle activity, gravity and
inertial loads. The compression load cell was zeroed with this
static load in place. Moment arms were measured. The target
torque level was set and measured using a spring scale acting
over the moment arm L1. Three values of P were targeted: 25
N, 50 N, and 100 N. Using Eqn. 1, the spring torque required to
generate each of these was calculated and applied to the VLD
in succession and the actual P generated, as measured by the
load cell, was recorded.
Results: For all data points, the measured P was within 14%
of the target P (Fig. 2). The slope of the least squares ﬁt line
through the data points was not signiﬁcantly different than 1.
Figure 2. Measured vs. target values of P with VLD application.
Conclusions: These results demonstrate the overall feasibility
of applying a known compressive overload, P, to the medial
compartment of the knee using the VLD. The ability to apply
consistent load alteration to the knee will allow the future study of
the dose response of articular cartilage to quantiﬁed levels of load
alteration in vivo.
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DIFFEFERENCE IN OSTEOPHYTE FORMATION AND SMAD
SIGNALING BETWEEN MURINE INFLAMMATORY
ARTHRITIS AND OSTEOARTHRITIS
P.M. van der Kraan, E.N. Blaney Davidson, M. Koenders,
J. Matualatupauw, A.B. Blom, I. Devesa, W.B. van den Berg
Radboud Univ., Med. Ctr., Nijmegen, Netherlands
Purpose: Osteophytes are a hallmark of osteoarthritis. In rheuma-
toid arthritis no osteophytes are found but profound bone depo-
sition is observed in ankylosing spondylitis. In animal models
the development of osteophytes is observed in both inﬂamma-
tory and degenerative joint diseases. In murine (osteo)arthritis
models, osteophyte formation appears to be the results of two
processes. New bone deposition via differentiating stem cells and
endochondral ossiﬁcation or through intramembranous deposition
by osteoblasts. We studied whether osteophyte formation differs
between murine inﬂammatory arthritis (IA) and osteoarthritis (OA),
and if dissimilar, what factors play a role in this unequal osteophyte
development.
Methods: We compared osteophyte formation in the following
OA models; spontaneous OA in Str/ort and collagenase-induced
osteoarthritis in C57Bl/6 mice. Inﬂammatory arthritis was studied
in collagen-induced arthritis in DBA-1J mice, streptococccal cell
wall-induced arthritis in C57Bl/6 mice and serum transfer-induced
arthritis in C57Bl/6 x 129Sv mice. Knee joints were dissected at
early as well as advanced time points during the development
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of OA and IA. Coronal sections were stained with fast green
and Safranin O and with speciﬁc antibodies for beta-catenin,
Smad2/3P, Smad1/5/8P and Runx2. Osteophyte formation and
immunohistochemical staining was scored on 11 locations in the
joint. In speciﬁc experiments, osteophyte formation in IA was
compared between wild-type and TNF alpha deﬁcient mice. Since
TNF-alpha-induced dickkopf1 has been suggested to be involved
in blocking osteophyte formation in arthritis, we have assessed
dickkopf1 expression arthritis in wild type and TNF alpha knock
out mice by RT-QPCR.
Results: In all OA and IA models, osteophytes that form through
endochondral bone formation were detected. Strikingly, intramem-
branous bone apposition, localized on the tibial and femoral bone
collar, was observed in the IA but not in the OA models. Immuno-
histochemistry of factors reported to be important in cartilage and
bone formation showed that expression of beta-catenin was found
in hypertrophic chondrocytes in osteophytes undergoing terminal
differentiation but not at sites that showed early osteophyte for-
mation. Expression of Runx2 was detected in more than 50%
of the cells at sites that showed early osteophyte formation in
both IA and OA models. Interestingly, at the same sites, IA and
OA models presented high Smad1/5/8P expression but only the
OA models showed also high Smad2/3P expression. No clear
Smad2/3P expression was found in the IA models.
In addition. TNF-alpha deﬁciency did not result in increased os-
teophyte formation. Moreover, severe arthritis in IA models was
associated with increased osteophyte formation but not with con-
comitantly decreased dickkopf-1 expression.
Conclusions: Intramembranous bone apposition was only ob-
served in IA models, indicating that bone formation in IA and
OA models is dissimilar. Absence of TNF-alpha did not result in
increased osteophyte formation, showing that neither TNF-alpha
itself nor TNF-alpha-induced dickkopf1 blocked osteophyte for-
mation in the models studied. Runx2 and TGF-beta superfamily
signaling was observed at site of early osteophyte formation. In
IA, Smad1/5/8P was expressed but Smad2/3P was absent. In OA
both Smad pathways were clearly activated. This suggest that ex-
pression of Smad1/5/8P is related to osteophyte formation by the
endochondral route while activation of Smad2/3P blocks intramem-
branous bone apposition. The balance of activated Smad2/3 and
Smad1/5/8 pathways appears to be involved in regulation of os-
teophyte formation in IA and OA.
103
ATTENUATION OF OSTEOARTHRITIS PROGRESSION BY
REDUCTION OF EXPRESSION OF DISCOIDIN DOMAIN
RECEPTOR 2
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Purpose: The objective of this study is to investigate if reduction
of DDR2 expression attenuates OA progression induced either by
a genetic mutation or by an non-genetic factor.
Methods: We generated double-heterozygous mutant mice, type
XI collagen- and Ddr2-haploinsufﬁcient mice in this study. We also
performed microsurgery on knee joints of Ddr2-deﬁcient mice. We
anticipate that the reduction of the Ddr2 expression will attenuate
the OA progression in mouse knee joints induced either by deﬁ-
ciency of type XI collagen or by the microsurgery. A serial parafﬁn
sections were prepared from the knee joints of the mice at differ-
ent stages of the disease. The articular cartilages of the mouse
knee joints were examined by Safranine O/Fast green staining.
Morphological conditions of the articular cartilages of the mouse
knee joints were evaluated by a modiﬁed Mankin score system.
The Ddr2 and Mmp13 protein expression proﬁles were examined
by immunohistostaining in the mouse knee joints.
Results: Results from histology showed that the OA pathological
progression was delayed in knee joints of double-heterozygous
mutant mice and the OA pathological progression induced surgi-
cally in knee joints of Ddr2-deﬁcient mice was also delayed. The
expression of Ddr2 and Mmp-13 was reduced in the knee joints of
the double-heterozygous mutant mice, compared with that in the
wild-type littermates at each time point when we examined.
Conclusions: Taken all above-mentioned results, it suggests that
the reduction of Ddr2 expression attenuates the OA progression
in mouse OA knee joints.
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A POSSIBLE ROLE OF HTRA1, A SERINE PROTEASE, IN
PATHOGENESIS OF OSTEOARTHRITIS
Y. Li1, I. Polur2, P.L. Lee2, J.M. Servais2, L. Xu1
1Harvard Sch. of Dental Med. and Harvard Med. Sch., Boston,
MA; 2Harvard Sch. of Dental Med., Boston, MA
Purpose: The objective of this study is to investigate a possible
role of HTRA1, a serine protease, in pathogenesis of OA by use
of four different mouse OA models.
Methods: In this study we examined the protein expression proﬁle
of Htra1 in the knee and temporomandibular (TM) joints of four
mouse OA models; two of the models had genetic forms of OA
and two had non-genetic forms of OA. The level of Htra1 mRNA
in the articular cartilage of knee joints, taken from one of the
genetically mutated models, was also examined. This was done
with the purpose of determining whether the increased expression
of Htra1 protein was paralleled by an up-regulated expression of
Htra1. Finally, we examined whether the increased expression of
Htra1 resulted in the disappearance of type VI collagen, which
is a good indicator of the integrity of the pericellular matrix of
chondrocytes, and thus led to the elevated expression of Ddr2 in
the knee joints of the mutant mice. Parafﬁn sections were prepared
from the knee and temporomandibular (TM) joints of four mouse
OA models; two of the models had a genetic mutation (type IX
collagen-deﬁcient and type XI collagen-haploinsufﬁcient) and two
were surgically induced (destabilization of the medial meniscus of
knee joint and discectomy). The Htra1 protein expression proﬁles
of the prepared sections were examined by immunohistostaining.
The level of Htra1 mRNA in the articular cartilage taken from the
knee joints of one of the genetically mutated OA models was
determined by real-time PCR. Double immunohistostaining was
used to examine the expression of co-localization of Htra1 with
type VI collagen and Htra1 with discoidin domain receptor 2 in the
articular cartilage of knee joints from the genetically mutated OA
model.
Results: The expression of Htra1 was found to be increased
in the knee and TM joints of the four mouse OA models at early
stages of the disease. An examination of the knee joint of a mutant
mouse indicated an 8-fold increase in the level of Htra1 mRNA,
when compared to the levels observed in the knee joints of its
wild-type littermates. Pericellular type VI collagen was not present
in chondrocytes expressing Htra1. Meanwhile, expression of Htra1
was associated with the expression of Ddr2 in the chondrocytes.
Conclusions: Results indicate that Htra1 may disrupt the peri-
cellular matrix network, resulting in the alteration of chondrocyte
metabolisms. This eventually leads to OA.
